Key result
Hypoxia-induced ANGPTL4 promotes NSCLC radioresistance by inhibiting GPX4-dependent ferroptosis.
Why the study?
Hypoxia-mediated radioresistance contributes to adverse radiotherapy outcomes in NSCLC, but the underlying molecular mechanisms remain obscure.
Hypoxia-induced ANGPTL4 promotes radioresistance in non-small cell lung cancer by inhibiting ferroptosis, highlighting a potential therapeutic target to improve radiotherapy efficacy.
Answers are grounded in this paper and cite their sources.
May support ANGPTL4-ferroptosis targeting to overcome hypoxic radioresistance in NSCLC; leaves open human translation.
BACKGROUND: Hypoxia-mediated radioresistance is a major reason for the adverse radiotherapy outcome of non-small cell lung cancer (NSCLC) in clinical, but the underlying molecular mechanisms are still obscure. METHODS: Cellular and exosomal ANGPTL4 proteins under different oxygen status were examined. Colony survival, lipid peroxidation and hallmark proteins were employed to determine the correlation between ferroptosis and radioresistance. Gene regulations, western blot and xenograft models were used to explore the underlying mechanisms of the role of ANGPTL4 in radioresistance. RESULTS: ANGPTL4 had a much higher level in hypoxic NSCLC cells compared to normoxic cells. Up- or down- regulation of ANGPTL4 positively interrelated to the radioresistance of NSCLC cells and xenograft tumours. GPX4-elicited ferroptosis suppression and lipid peroxidation decrease were authenticated to be involved in the hypoxia-induced radioresistance. ANGPTL4 encapsulated in the exosomes from hypoxic cells was absorbed by neighbouring normoxic cells, resulting in radioresistance of these bystander cells in a GPX4-dependent manner, which was diminished when ANGPTL4 was downregulated in the donor exosomes. CONCLUSION: Hypoxia-induced ANGPTL4 rendered radioresistance of NSCLC through at least two parallel pathways of intracellular ANGPTL4 and exosomal ANGPTL4, suggesting that ANGPTL4 might applicable as a therapeutic target to improve the therapeutic efficacy of NSCLC.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied Non-small cell lung cancer. ANGPTL4 modulation and exosomal transfer vs. Control (normoxia or negative control vectors) was evaluated. Hypoxia-induced ANGPTL4 promoted radioresistance in non-small cell lung cancer through intracellular and exosomal pathways by inhibiting GPX4-dependent ferroptosis.
Synapse has enriched 10 related papers. Consider them for comparative context: